Loading clinical trials...
Loading clinical trials...
Understanding Circadian Responses to Light in Persons With Mild Cognitive Impairment and Alzheimer's Disease
The purpose of this research study is to investigate the relationship between light, the thickness of the pigment at the back of your eye, melatonin levels, and memory. The study will investigate whether changing light distribution pattern from "on-axis"' (i.e., directed along the eye's visual axis to the fovea) to "off-axis" (i.e., directed on the periphery of the eye's visual axis) impact melatonin suppression in 24 mild cognitive impairment participants and 24 healthy, age-matched controls.
Eligible enrolled subjects will be exposed to 4 different lighting conditions in addition to one dark control condition. There will be 5 study session and each one will last for 90 minutes and will be separated by one week. Subjects will collect 3 saliva samples, each one 30 minutes apart for melatonin levels during each study session.
Age
55 - No limit years
Sex
ALL
Healthy Volunteers
Yes
Light and Health Research Center at Mount Sinai
Menands, New York, United States
Start Date
June 14, 2021
Primary Completion Date
May 31, 2024
Completion Date
May 31, 2024
Last Updated
June 24, 2025
36
ACTUAL participants
Lighting Intervention Blue light
DEVICE
Lighting Intervention Green light
DEVICE
Dim-light control condition
OTHER
Lead Sponsor
Icahn School of Medicine at Mount Sinai
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT07178210